Inflammatory myopathies (polymyositis, dermatomyositis, inclusion body myositis)

Comprehensive Therapy

Volumn 24, Issue 10, 1998, Pages 494-502

  Bertorini, Tulio E ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE;

ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CREATINE KINASE BLOOD LEVEL; CUSHING DISEASE; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; ELECTROMYOGRAM; EYELID EDEMA; GLYCOGEN STORAGE DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCLUSION BODY MYOSITIS; INFLAMMATORY INFILTRATE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE WEAKNESS; PATHOGENESIS; POLYMYOSITIS; RASH;

DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MYOSITIS; MYOSITIS, INCLUSION BODY; POLYMYOSITIS;

EID: 0031722569     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Medsger TA, Dawson WN, Masi AT. The epidemiology of polymyositis. Am J Med. 1970;48:715-723.
2. Banker BQ, Engel AG. The polymyositis dermatomyositis syndrome. In: Engel AG, Banker BQ, eds. Myology. New York: McGraw-Hill; 1986:1385-1426.
3. Bohan A. Clinical presentation and diagnosis of polymyositis and dermatomyositis. In: Dalakas MC, ed. Polymyositis and Dermatomyositis. Boston, Mass: Butterworths; 1988:19-36.
4. Rose AL, Walton JN. Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis. Brain. 1966;89:747-768.
5. Bertorini TE. Electromyography in polymyositis and dermatomyositis (PM/DM). In: Dalakas MC, ed. Polymyositis and Dermatomyositis. Boston, Mass: Butterworths; 1988:217-234.
6. Bertorini TE. Histopathology of the inflammatory myopathies. In: Dalakas MC, ed. Polymyositis and Dermatomyositis. Boston, Mass: Butterworths; 1988:157-194.
7. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:344-347.
8. Tashimoto K, Nakano K, Kano S, et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol. 1995;22: 668-674.
9. Griggs RC, Askanas V, DiMauro S, et al. Inclusion body myositis and myopathies. Ann Neurol. 1995;38:705-713.
10. Yunis EJ, Samaha FJ. Inclusion body myositis. Lab Invest. 1971;25:240-248.
11. Carpenter S, Karpati G, Heller I, Eisen A. Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology. 1978;28:8-17.
12. Miller FW. Myositis-specific autoantibodies: touchstones for understanding the inflammatory myopathies. JAMA. 1993; 270:1846-1849.
13. Chariot P, Ruet E, Authier F-J, Labes D, Poron F, Gherardi R. Cytochrome c oxidase deficiencies in the muscle of patients with inflammatory myopathies. Acta Neuropathol. 1996;91:530-536.
14. Mendell J, Sahenk Z, Gales T, Paul L. Amyloid filaments in inclusion body myositis: novel findings provide insight into nature of filaments. Arch Neurol. 1991;48:1229-1234.
15. Santorelli FM, Sciacco M, Tanji K, et al. Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients. Ann Neurol. 1996;39:789-795.
16. Walton JN, Adams RD, eds. Polymyositis. Baltimore, Md: Williams & Wilkins; 1958.
17. Henriksson KG, Sandstedt P. Polymyositis-treatment and prognosis: a study of 107 patients. Acta Neurol Scand. 1982; 65:280-300.
18. Gamboa ET, Eastwood AB, Hays AP, et al. Isolation of influenza virus from muscle in myoglobinuria polymyositis. Neurology. 1979;29:1323-1335.
19. Rosenberg NL, Rotbart HA, Abzug MJ, et al. Evidence for a novel picornavirus in human dermatomyositis. Ann Neurol. 1989;26:204-209.
20. Arahata K, Engel A. Monoclonal antibody analysis of mononuclear cells in myopathies. IV Cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol. 1988;23:168-173.
21. Karpati G, Pouliot Y, Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol. 1988; 23:64-72.
22. Whitaker JN, Engel WK. Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med. 1972;286:333-338.
23. Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med. 1986;314:329-334.
24. Kissel JT, Halterman RK, Rammohan KW, Mendell JR. The relationship of complement-mediated micro vasculopathy of the histologic features and clinical duration of the disease in dermatomyositis. Arch Neurol. 1991;48:26-30.
25. Illa I, Nath A, Dalakas M. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol. 1991;29:474-481.
26. Leon-Monzon ML, Dalakas MC. Detection of HIV in muscle and nerve biopsies by DNA amplification techniques. Neurology. 1991;41(S):1-211.
27. Leon-Monzon M, Illa I, Dalakas MC. Polymyositis in patients infected with human T-cell leukemia virus type I: the role of the virus in the cause of the disease. Ann Neurol. 1994;36:643-649.
28. Moufarrej NA, Bertorini, TE. Respiratory insufficiency in adult-type acid maltase deficiency. Southern Med J. 1993;86: 560-567.
29. Dalakas MC. Treatment of polymyositis and dermatomyositis with corticosteroids: A first therapeutic approach. In: Dalakas MC, ed. Polymyositis and Dermatomyositis. Boston, Mass: Butterworths; 1988:235-253.
30. Kula RW. Nonsteroidal immunosuppressive therapy in polymyositis and dermatomyositis. In: Dalakas MC, ed. Polymyositis and Dermatomyositis. Boston, Mass: Butterworths; 1988:255-279.
31. Dalakas MC. Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med. 1991;325:1487-1498.
32. Dalakas MC, Illa I, Dambrosia JM, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med. 1993;329: 1993-2000.
33. Soueidan SA, Dalakas MC. Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin. Neurology. 1993;43:876-879.
34. Dalakas MC, Sonies B, Dambrosia J, et al. Treatment of inclusion-body myositis with IVIg: a double-blind. placebo-controlled study. Neurology. 1997; 48: 712-716.
35. Bertorini TE, Nance A, Horner LH, Greene W, Gelfand M, Jaster H. Complications of intravenous gamma globulin infusions in neuromuscular diseases. Muscle Nerve. 1996;19: 388-391.